NASDAQ · Healthcare · Biotechnology
Caris Life Sciences, Inc.
CAI
Caris Life Sciences, Inc. CEO David Dean Halbert · Market cap $5.2B.
$18.50
-0.20 · -1.07%
52w hi $42.5052w lo $14.19
Off 52w high 60.6%
68
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
0 strong · 2 notable
Analyst consensus
Strong Buy
Avg PT $28.60
Section 01
Recent Form 4 filings
4 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| May 11 | Jeff L Vacirca | Buy | 31,050 | $16.15 | +$501K | 68 | |
| Nov 07 | John Russel Denton | Senior Vice President, General Counsel, and Secretary | Buy | 4,184 | $24.09 | +$101K | 69 |
| Jun 20 | Brian J Brille | Vice Chairman and Executive Vice President | Buy | 30,000 | $21.00 | +$630K | 78 |
| Jun 20 | John Russel Denton | Senior Vice President, General Counsel, and Secretary | Buy | 7,500 | $21.00 | +$158K | 69 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun